top of page
Starting August 1, 2024, Quickarrays, Inc. will be providing all products and services in place of Pantomics Inc.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
NPC231
Nasopharyngeal carcinoma tissue array, NPC231, non-overlapping with other NPC tissue arrays, containing 21 cases of primary tumors and 2 cases of metastatic tumors.
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$213
1 slide
In-Stock
A | |
B | |
C | |
Human
23
23
1.5mm
4um
3
8
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in nasopharyngeal carcinoma.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|
A01 | F | 48 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | III | ||
A02 | M | 53 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | III | ||
A03 | M | 32 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | III | ||
A04 | M | 51 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | III | ||
A05 | M | 54 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | III | ||
A06 | M | 48 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | III | ||
A07 | M | 62 | Head and neck, nasopharynx | Non-keratinizing differentiated carcinoma | II | ||
A08 | F | 35 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | III | ||
B01 | F | 45 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | III | ||
B02 | M | 49 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | III | ||
B03 | M | 38 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | III | ||
B04 | F | 67 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | III | ||
B05 | F | 50 | Head and neck, left neck, subcutaneous tissue | Metastatic or invasive Non-keratinizing undifferentiated carcinoma | III | ||
B06 | M | 60 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | III | ||
B07 | M | 48 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | III | ||
B08 | M | 66 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | III | ||
C01 | F | 36 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | III | ||
C02 | M | 42 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | III | ||
C03 | M | 51 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | III | ||
C04 | F | 51 | Head and neck, nasopharynx | Non-keratinizing differentiated carcinoma | II | ||
C05 | F | 50 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | III | ||
C06 | M | 33 | Head and neck, mastoid process | Metastatic or invasive Non-keratinizing undifferentiated carcinoma | III | ||
C07 | M | 51 | Head and neck, nasopharynx | Non-keratinizing undifferentiated carcinoma | III | ||
null |
bottom of page